Selected research
Market Structure
Global Non-GMP Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Non-GMP Development market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Non-GMP Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Non-GMP Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-GMP Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Non-GMP Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Non-GMP Development include Almac, GTP Technology, Alfa Aesar, Sundia-Manufacturing, J-STAR Research Inc., Lonza, AmbioPharm, Velesco and CordenPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Non-GMP Development market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Non-GMP Development and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Non-GMP Development revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Non-GMP Development market size, projected growth trends, production technologies, key applications, and end-use industries.
Non-GMP Development Segment by Company
Almac
GTP Technology
Alfa Aesar
Sundia-Manufacturing
J-STAR Research Inc.
Lonza
AmbioPharm
Velesco
CordenPharma
Piramal Pharma Solutions
Norwich
Aurigene Pharmaceutical Services
Actylis
CARBOGEN AMCIS
GTP Bioways
Symeres
Quotient Sciences
Non-GMP Development Segment by Type
Research Grade
Animal Free Grade
Non-GMP Development Segment by Application
Commercial & Academic
Clinical
Others
Non-GMP Development Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-GMP Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-GMP Development and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-GMP Development.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Non-GMP Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-GMP Development industry.
Chapter 3: Detailed analysis of Non-GMP Development companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-GMP Developmentrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Research Grade
- Animal Free Grade
Applications
- Commercial & Academic
- Clinical
- Others
Companies covered
- Almac
- GTP Technology
- Alfa Aesar
- Sundia-Manufacturing
- J-STAR Research Inc.
- Lonza
- AmbioPharm
- Velesco
- CordenPharma
- Piramal Pharma Solutions
- Norwich
- Aurigene Pharmaceutical Services
- Actylis
- CARBOGEN AMCIS
- GTP Bioways
- Symeres
- Quotient Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Non-GMP Development Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Research Grade
- 1.2.3 Animal Free Grade
- 1.3 Market Analysis by Application
- 1.3.1 Global Non-GMP Development Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Commercial & Academic
- 1.3.3 Clinical
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Non-GMP Development Growth Trends by Region
- 1.5.1 Global Non-GMP Development Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Non-GMP Development Market Size by Region (2021-2026)
- 1.5.3 Non-GMP Development Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Non-GMP Development Market Dynamics
- 2.1 Non-GMP Development Industry Trends
- 2.2 Non-GMP Development Industry Drivers
- 2.3 Non-GMP Development Industry Opportunities and Challenges
- 2.4 Non-GMP Development Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Non-GMP Development Revenue by Company (2021-2026)
- 3.2 Global Non-GMP Development Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Non-GMP Development Key Company Head office and Area Served
- 3.4 Global Non-GMP Development Company, Product Type & Application
- 3.5 Global Non-GMP Development Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Non-GMP Development Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Non-GMP Development Players Market Share by Revenue in 2025
- 3.6.3 2025 Non-GMP Development Tier 1, Tier 2, and Tier 3
4 Non-GMP Development Market by Type
- 4.1 Global Non-GMP Development Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Non-GMP Development Market Size by Type (2021-2032)
- 4.3 Global Non-GMP Development Market Size Share by Type (2021-2032)
5 Non-GMP Development Market by Application
- 5.1 Global Non-GMP Development Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Non-GMP Development Market Size by Application (2021-2032)
- 5.3 Global Non-GMP Development Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Almac
- 6.1.1 Almac Company Information
- 6.1.2 Almac Business Overview
- 6.1.3 Almac Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Almac Non-GMP Development Product Portfolio
- 6.1.5 Almac Recent Developments
- 6.2 GTP Technology
- 6.2.1 GTP Technology Company Information
- 6.2.2 GTP Technology Business Overview
- 6.2.3 GTP Technology Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GTP Technology Non-GMP Development Product Portfolio
- 6.2.5 GTP Technology Recent Developments
- 6.3 Alfa Aesar
- 6.3.1 Alfa Aesar Company Information
- 6.3.2 Alfa Aesar Business Overview
- 6.3.3 Alfa Aesar Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Alfa Aesar Non-GMP Development Product Portfolio
- 6.3.5 Alfa Aesar Recent Developments
- 6.4 Sundia-Manufacturing
- 6.4.1 Sundia-Manufacturing Company Information
- 6.4.2 Sundia-Manufacturing Business Overview
- 6.4.3 Sundia-Manufacturing Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sundia-Manufacturing Non-GMP Development Product Portfolio
- 6.4.5 Sundia-Manufacturing Recent Developments
- 6.5 J-STAR Research Inc.
- 6.5.1 J-STAR Research Inc. Company Information
- 6.5.2 J-STAR Research Inc. Business Overview
- 6.5.3 J-STAR Research Inc. Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 J-STAR Research Inc. Non-GMP Development Product Portfolio
- 6.5.5 J-STAR Research Inc. Recent Developments
- 6.6 Lonza
- 6.6.1 Lonza Company Information
- 6.6.2 Lonza Business Overview
- 6.6.3 Lonza Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Lonza Non-GMP Development Product Portfolio
- 6.6.5 Lonza Recent Developments
- 6.7 AmbioPharm
- 6.7.1 AmbioPharm Company Information
- 6.7.2 AmbioPharm Business Overview
- 6.7.3 AmbioPharm Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 AmbioPharm Non-GMP Development Product Portfolio
- 6.7.5 AmbioPharm Recent Developments
- 6.8 Velesco
- 6.8.1 Velesco Company Information
- 6.8.2 Velesco Business Overview
- 6.8.3 Velesco Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Velesco Non-GMP Development Product Portfolio
- 6.8.5 Velesco Recent Developments
- 6.9 CordenPharma
- 6.9.1 CordenPharma Company Information
- 6.9.2 CordenPharma Business Overview
- 6.9.3 CordenPharma Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 CordenPharma Non-GMP Development Product Portfolio
- 6.9.5 CordenPharma Recent Developments
- 6.10 Piramal Pharma Solutions
- 6.10.1 Piramal Pharma Solutions Company Information
- 6.10.2 Piramal Pharma Solutions Business Overview
- 6.10.3 Piramal Pharma Solutions Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Piramal Pharma Solutions Non-GMP Development Product Portfolio
- 6.10.5 Piramal Pharma Solutions Recent Developments
- 6.11 Norwich
- 6.11.1 Norwich Company Information
- 6.11.2 Norwich Business Overview
- 6.11.3 Norwich Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Norwich Non-GMP Development Product Portfolio
- 6.11.5 Norwich Recent Developments
- 6.12 Aurigene Pharmaceutical Services
- 6.12.1 Aurigene Pharmaceutical Services Company Information
- 6.12.2 Aurigene Pharmaceutical Services Business Overview
- 6.12.3 Aurigene Pharmaceutical Services Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Aurigene Pharmaceutical Services Non-GMP Development Product Portfolio
- 6.12.5 Aurigene Pharmaceutical Services Recent Developments
- 6.13 Actylis
- 6.13.1 Actylis Company Information
- 6.13.2 Actylis Business Overview
- 6.13.3 Actylis Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Actylis Non-GMP Development Product Portfolio
- 6.13.5 Actylis Recent Developments
- 6.14 CARBOGEN AMCIS
- 6.14.1 CARBOGEN AMCIS Company Information
- 6.14.2 CARBOGEN AMCIS Business Overview
- 6.14.3 CARBOGEN AMCIS Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 CARBOGEN AMCIS Non-GMP Development Product Portfolio
- 6.14.5 CARBOGEN AMCIS Recent Developments
- 6.15 GTP Bioways
- 6.15.1 GTP Bioways Company Information
- 6.15.2 GTP Bioways Business Overview
- 6.15.3 GTP Bioways Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 GTP Bioways Non-GMP Development Product Portfolio
- 6.15.5 GTP Bioways Recent Developments
- 6.16 Symeres
- 6.16.1 Symeres Company Information
- 6.16.2 Symeres Business Overview
- 6.16.3 Symeres Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Symeres Non-GMP Development Product Portfolio
- 6.16.5 Symeres Recent Developments
- 6.17 Quotient Sciences
- 6.17.1 Quotient Sciences Company Information
- 6.17.2 Quotient Sciences Business Overview
- 6.17.3 Quotient Sciences Non-GMP Development Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Quotient Sciences Non-GMP Development Product Portfolio
- 6.17.5 Quotient Sciences Recent Developments
7 North America
- 7.1 North America Non-GMP Development Market Size (2021-2032)
- 7.2 North America Non-GMP Development Market Size by Type
- 7.2.1 North America Non-GMP Development Market Size by Type (2021-2026)
- 7.2.2 North America Non-GMP Development Market Size by Type (2027-2032)
- 7.2.3 North America Non-GMP Development Market Share by Type (2021-2032)
- 7.3 North America Non-GMP Development Market Size by Application
- 7.3.1 North America Non-GMP Development Market Size by Application (2021-2026)
- 7.3.2 North America Non-GMP Development Market Size by Application (2027-2032)
- 7.3.3 North America Non-GMP Development Market Share by Application (2021-2032)
- 7.4 North America Non-GMP Development Market Size by Country
- 7.4.1 North America Non-GMP Development Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Non-GMP Development Market Size by Country (2021-2026)
- 7.4.3 North America Non-GMP Development Market Size by Country (2027-2032)
- 7.4.4 North America Non-GMP Development Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Non-GMP Development Market Size (2021-2032)
- 8.2 Europe Non-GMP Development Market Size by Type
- 8.2.1 Europe Non-GMP Development Market Size by Type (2021-2026)
- 8.2.2 Europe Non-GMP Development Market Size by Type (2027-2032)
- 8.2.3 Europe Non-GMP Development Market Share by Type (2021-2032)
- 8.3 Europe Non-GMP Development Market Size by Application
- 8.3.1 Europe Non-GMP Development Market Size by Application (2021-2026)
- 8.3.2 Europe Non-GMP Development Market Size by Application (2027-2032)
- 8.3.3 Europe Non-GMP Development Market Share by Application (2021-2032)
- 8.4 Europe Non-GMP Development Market Size by Country
- 8.4.1 Europe Non-GMP Development Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Non-GMP Development Market Size by Country (2021-2026)
- 8.4.3 Europe Non-GMP Development Market Size by Country (2027-2032)
- 8.4.4 Europe Non-GMP Development Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Non-GMP Development Market Size (2021-2032)
- 9.2 China Non-GMP Development Market Size by Type
- 9.2.1 China Non-GMP Development Market Size by Type (2021-2026)
- 9.2.2 China Non-GMP Development Market Size by Type (2027-2032)
- 9.2.3 China Non-GMP Development Market Share by Type (2021-2032)
- 9.3 China Non-GMP Development Market Size by Application
- 9.3.1 China Non-GMP Development Market Size by Application (2021-2026)
- 9.3.2 China Non-GMP Development Market Size by Application (2027-2032)
- 9.3.3 China Non-GMP Development Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Non-GMP Development Market Size (2021-2032)
- 10.2 Asia Non-GMP Development Market Size by Type
- 10.2.1 Asia Non-GMP Development Market Size by Type (2021-2026)
- 10.2.2 Asia Non-GMP Development Market Size by Type (2027-2032)
- 10.2.3 Asia Non-GMP Development Market Share by Type (2021-2032)
- 10.3 Asia Non-GMP Development Market Size by Application
- 10.3.1 Asia Non-GMP Development Market Size by Application (2021-2026)
- 10.3.2 Asia Non-GMP Development Market Size by Application (2027-2032)
- 10.3.3 Asia Non-GMP Development Market Share by Application (2021-2032)
- 10.4 Asia Non-GMP Development Market Size by Country
- 10.4.1 Asia Non-GMP Development Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Non-GMP Development Market Size by Country (2021-2026)
- 10.4.3 Asia Non-GMP Development Market Size by Country (2027-2032)
- 10.4.4 Asia Non-GMP Development Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Non-GMP Development Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Non-GMP Development Market Size by Type
- 11.2.1 South America, Middle East & Africa Non-GMP Development Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Non-GMP Development Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Non-GMP Development Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Non-GMP Development Market Size by Application
- 11.3.1 South America, Middle East & Africa Non-GMP Development Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Non-GMP Development Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Non-GMP Development Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Non-GMP Development Market Size by Country
- 11.4.1 South America, Middle East & Africa Non-GMP Development Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Non-GMP Development Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Non-GMP Development Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Non-GMP Development Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst